Skip to content

Midazolam Efficacy for Sedating Preschoolers Undergoing Dental Treatment

A Randomised Controlled Trial of Pediatric Sedation for Dental Treatment Using Oral Midazolam or Placebo

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01795222
Acronym
Pedsed-I
Enrollment
18
Registered
2013-02-20
Start date
2012-03-31
Completion date
2013-02-28
Last updated
2013-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Childhood Caries

Keywords

conscious sedation, stress psychological, dental care for children, child behavior, saliva

Brief summary

Evaluation of oral midazolam to improve children's behavior and reduces the stress and anxiety during dental treatment

Detailed description

This study was initially planned to investigate three paediatric sedation regimens that also included the following arms: * oral midazolam + oral ketamine + inhaled sevoflurane * oral midazolam + oral ketamine + inhaled oxygen So, the former protocol found in the PRS registry was called PedSed-III and included the aforementioned arms. However, there was a long delay in fund release from the funding agency (State of Goias Research Foundation - FAPEG). Although the grant was approved in the beginning of 2013, resources were released in November 2013. We could not wait for funding release because this study was part of the MS dissertation of the principal investigator that was supposed to be concluded in the first semester of 2013. Then we decided to develop a less robust study, including only two arms: oral midazolam versus oral placebo. The other variables of the study did not change. We finished this two-arms study and have the final results for that comparison.

Interventions

DRUGMidazolam

Dormire: Midazolam oral solution 2 mg/mL Sedative was administered with a syringe by the anaesthesiologist

DRUGPlacebo

Magistral formula prepared to match Dormire color and consistency, without active ingredients Placebo was administered the same way as midazolam

Sponsors

Federal University of Minas Gerais
CollaboratorOTHER
Universidade Federal de Goias
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 2 to 5 years old, American Society of Anesthesiologists (ASA) I or II, healthy, with no cognitive impairment, presenting with early childhood caries

Exclusion criteria

* Children presenting with at least one of the following: * airway obstruction and/or oral breathing; * recent use of systemic corticosteroids * needing less than two dental restorations; * previous dental sedation.

Design outcomes

Primary

MeasureTime frameDescription
child stressAt child's awaking and arrival in the dental office, 25 min after local anesthetic administration, 25 min after dental session completionlevel of salivary cortisol according to the ELISA

Secondary

MeasureTime frameDescription
Child behaviourevery minute during the dental treatment up to the end of the dental session, which is estimated in 60 minuteschild dental treatment is video recorded and then a masked observer watches the videos and categorize child behavior according to the Ohio State University Behavioral Rating Scale (OSUBRS)
sedative safetyduring and twenty four hours after the procedureassessed according to the World SIVA adverse sedation event reporting tool

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026